[1]
“Benefits and Risks of Prolonged Cotrimoxazole Prophylaxis among People Living with HIV in Immune Reconstitution Phase: A Retrospective Cohort Study”, Acta Med Philipp, vol. 54, no. 3, Jun. 2020, doi: 10.47895/amp.v54i3.1657.